Triptorelin in treatment of cervical and vaginal dysplasia related to papillomavirus.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003218:Condylomata Acuminata / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae; D013997:Time Factors; D017329:Triptorelin Pamoate; D014412:Tumor Virus Infections / Q000188:drug therapy*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*; D014625:Vaginal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone